Searching in Banking & Finance · Search everything

1,305 changes

Favicon for www.osfi-bsif.gc.ca

OSFI Finalizes Liquidity Adequacy Requirements Guideline

The Office of the Superintendent of Financial Institutions (OSFI) has published the final Liquidity Adequacy Requirements (LAR) Guideline for 2026. This guideline, effective May 1, 2026, clarifies definitions and treatments for deposits and structured notes to enhance the financial resilience of federally regulated deposit-taking institutions.

Priority review Guidance Banking
Favicon for www.osfi-bsif.gc.ca

OSFI Discusses Canadian Banking Risks and Regulations

Superintendent Peter Routledge of OSFI discussed key risks facing Canadian financial institutions, including credit, liquidity, and governance. OSFI has launched consultations on credit risk management guidance and senior leader accountability, and issued final liquidity adequacy requirements.

Priority review Guidance Banking
Favicon for www.osfi-bsif.gc.ca

OSFI Superintendent Discusses Climate Risk at CatIQ Conference

OSFI Superintendent Peter Routledge discussed the findings of the first Climate Risk Returns from 10 large Canadian institutions at the 2026 CatIQ conference. The returns provide detailed insights into physical and transition climate risks across various asset classes and sectors, highlighting areas of vulnerability and the need for improved data discipline.

Priority review Notice Environmental Protection
1mo ago ESMA Document Library
Favicon for www.esma.europa.eu

ESMA Notifications of Compliance with Guidelines Overview Table

The European Securities and Markets Authority (ESMA) has published an overview table detailing notifications of compliance with its guidelines. This document serves as a reference for market participants regarding adherence to ESMA's technical standards and guidelines.

Routine Notice Securities
1mo ago ESMA Document Library
Favicon for www.esma.europa.eu

MiCA Reverse Solicitation Guidelines Compliance Table

The European Securities and Markets Authority (ESMA) has published a compliance table for its Markets in Crypto-Assets (MiCA) Regulation reverse solicitation guidelines. This document aims to assist entities in understanding and adhering to the new requirements regarding unsolicited marketing of crypto-asset services.

Routine Guidance Securities
1mo ago ESMA Document Library
Favicon for www.esma.europa.eu

MiCA Crypto-Asset Transfer Guidelines Compliance Table

The European Securities and Markets Authority (ESMA) has published a compliance table for its MiCA crypto-asset transfer guidelines. This document serves as a reference for entities to assess their adherence to the new regulatory framework for crypto-asset service providers.

Routine Guidance Securities
Favicon for www.sec.gov

SEC v. Ryan Squillante - Insider Trading Enforcement

The SEC announced a final consent judgment against Ryan Squillante for insider trading. Squillante was ordered to pay disgorgement and prejudgment interest totaling $250,765, which was satisfied by a criminal fine in a parallel case. The SEC alleges he used confidential information to trade in at least ten securities.

Urgent Enforcement Securities
Favicon for www.sec.gov

SEC Obtains Judgments Against Shvartsman Brothers for Insider Trading

The SEC announced it obtained final consent judgments against Gerald and Michael Shvartsman for insider trading in DWAC securities, resulting in disgorgement of over $22 million. The action also involved parallel criminal proceedings, and the SEC voluntarily dismissed its claims against Rocket One Capital LLC.

Urgent Enforcement Securities
Favicon for www.sec.gov

SEC Charges Marat Likhtenstein with $4 Million Offering Fraud

The SEC has charged Marat Likhtenstein with an offering fraud scheme that raised over $4.1 million. Likhtenstein allegedly misappropriated investor funds for personal expenses and Ponzi-like payments. He consented to injunctive relief, with monetary relief to be determined.

Urgent Enforcement Securities
Favicon for www.sec.gov

SEC Charges CBA Pharma and Two Executives with Fraud

The SEC has charged CBA Pharma, Inc. and two executives with defrauding investors in a securities offering that raised approximately $4.1 million. The company allegedly misrepresented the effectiveness and FDA approval status of its cancer drug, CBT-1.

Urgent Enforcement Securities

Showing 1271–1280 of 1,305 changes

1 126 127 128 129 130 131

Get alerts for ""

We'll email you when new changes match this search.

Free. Unsubscribe anytime.